We are live on ! Find out more
CANY

Caxton Associates (New York) Portfolio holdings

AUM $3.18B
1-Year Est. Return 54.49%
This Fund
S&P 500
This Quarter Est. Return
-18.82%
1 Year Est. Return
+54.49%
3 Year Est. Return
+73.91%
5 Year Est. Return
+212.89%
10 Year Est. Return
+632.2%
AUM
$1.03B
AUM Growth
-$200M
Cap. Flow
+$16M
Cap. Flow %
1.55%
Top 10 Hldgs %
58.26%
Holding
811
New
317
Increased
98
Reduced
90
Closed
269

Top Buys

Rank Stock Value
1
VAL icon
Valaris
VAL
+$24.3M
2
MRNA icon
Moderna
MRNA
+$9.63M
3
SLV icon
iShares Silver Trust
SLV
+$9.23M
4
TMUS icon
T-Mobile US
TMUS
+$9.02M
5
NE icon
Noble Corp
NE
+$6.74M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$107M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$29M
3
APTV icon
Aptiv
APTV
+$22.6M
4
MSFT icon
Microsoft
MSFT
+$20.8M
5
AMZN icon
Amazon
AMZN
+$12.7M

Sector Composition

Rank Sector Weight
1 Healthcare 23.31%
2 Consumer Discretionary 12.31%
3 Materials 12.15%
4 Industrials 5.19%
5 Financials 4.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KTOS icon
376
Kratos Defense & Security Solutions
KTOS
$11.7B
$311K 0.03%
+22,442
New +$349K
NXPI icon
377
NXP Semiconductors
NXPI
$59.4B
$311K 0.03%
+2,101
New +$365K
ATVI
378
DELISTED
Activision Blizzard
ATVI
$311K 0.03%
+4,000
New +$311K
VNT icon
379
Vontier
VNT
$4.69B
$310K 0.03%
+13,473
New +$345K
CBAY
380
DELISTED
Cymabay Therapeutics
CBAY
$310K 0.03%
105,202
-12,700
-11% -$30.3K
TTWO icon
381
Take-Two Interactive
TTWO
$47.3B
$309K 0.03%
+2,525
New +$321K
JKS
382
JinkoSolar
JKS
$889M
$306K 0.03%
+4,424
New +$248K
HAIN icon
383
Hain Celestial
HAIN
$55M
$305K 0.03%
+12,856
New +$366K
VITL icon
384
Vital Farms
VITL
$495M
$304K 0.03%
34,711
+7,214
+26% +$76.8K
FANG icon
385
Diamondback Energy
FANG
$54.9B
$303K 0.03%
+2,500
New +$343K
TRMB icon
386
Trimble
TRMB
$13.8B
$303K 0.03%
5,204
-760
-13% -$49.9K
CRK icon
387
Comstock Resources
CRK
$4.19B
$300K 0.03%
24,853
-12,347
-33% -$204K
EGP icon
388
EastGroup Properties
EGP
$10.8B
$299K 0.03%
+1,939
New +$340K
MIDD icon
389
Middleby
MIDD
$5.9B
$299K 0.03%
+2,385
New +$344K
EXPO icon
390
Exponent
EXPO
$3.25B
$296K 0.03%
+3,238
New +$305K
COP icon
391
ConocoPhillips
COP
$146B
$293K 0.03%
3,266
-3,177
-49% -$327K
OMC icon
392
Omnicom Group
OMC
$23B
$292K 0.03%
4,590
-2,329
-34% -$172K
TGTX icon
393
TG Therapeutics
TGTX
$7.5B
$292K 0.03%
+68,677
New +$429K
ICUI icon
394
ICU Medical
ICUI
$4.62B
$289K 0.03%
+1,758
New +$338K
LOCO icon
395
El Pollo Loco
LOCO
$471M
$288K 0.03%
29,286
+16,921
+137% +$178K
RDUS
396
DELISTED
Radius Recycling
RDUS
$288K 0.03%
+8,768
New +$374K
RPM icon
397
RPM International
RPM
$14.7B
$286K 0.03%
+3,631
New +$305K
SMTC icon
398
Semtech
SMTC
$12.7B
$284K 0.03%
5,166
TNK icon
399
Teekay Tankers
TNK
$2.65B
$284K 0.03%
+16,097
New +$287K
HES
400
DELISTED
Hess
HES
$281K 0.03%
2,650
+845
+47% +$95.6K

Similar funds

Caxton Associates (New York)'s Q2 2022 Portfolio in Review

As of Q2 2022, Caxton Associates (New York) held 811 positions worth $1.03B, down 16% from $1.23B the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Caxton Associates (New York)'s Q2 2022 filing shows 317 new, 98 increased, 90 reduced and 269 closed positions. Its largest new stake was Valaris: 451,426 shares worth $19.1M. The largest sale was Tesla, an estimated $107M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Materials.

  • Caxton Associates (New York)'s largest Q2 2022 buy was Valaris: 451,426 shares worth $19.1M.
  • Caxton Associates (New York) added most to Moderna in Q2 2022, an estimated $9.63M increase.
  • Caxton Associates (New York)'s biggest Q2 2022 reduction was Aptiv, cutting an estimated $22.6M.
  • Caxton Associates (New York) fully exited Tesla in Q2 2022, selling an estimated $107M.
  • Caxton Associates (New York)'s ten largest holdings make up 58% of its $1.03B portfolio in Q2 2022.
  • Caxton Associates (New York) opened 317 new positions and closed 269 in Q2 2022.
  • Caxton Associates (New York)'s portfolio value fell 16% quarter-over-quarter to $1.03B.

Based on Caxton Associates (New York)'s 13F filing for Q2 2022, filed 15 Aug 2022.